Skip to main content

Inovio's experimental Covid-19 vaccine moving to Warp Speed after positive study results

The Plymouth Meeting company said 94% of the clinical trial participants demonstrated overall immune responses after two doses.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.